Bank Can't Collect $10M Fees From Hemispherx: 3rd Circ.
The Third Circuit on Friday affirmed a Delaware federal judge's decision that an investment bank couldn't collect $9.8 million in fees from biotech company Hemispherx Biopharma Inc., saying the bank failed...To view the full article, register now.
Already a subscriber? Click here to view full article